この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
市場規制 · 1996/4/171 分で読めます
Arizona Institute of Reproductive Medicine, Ltd.; Prohibited Trade Practices, and Affirmative Corrective Actions
ローカル自動翻訳 · 情報源の原言語
概要
In settlement of alleged violations of federal law prohibiting unfair or deceptive acts or practices and unfair methods of competition, this consent order prohibits, among other things, an Arizona institute and its president from misrepresenting the success rate of their in vitro fertilization program or any other infertility treatment services. In addition, the consent order stipulates that any comparison with other success rates be based upon the same calculating methodology. Finally, the order requires the respondents to possess competent and reliable scientific evidence for any future comparative success-rate claims for fertility services.
情報源の原言語: Federal Register — Federal Trade Commission原文の発表を開く →